<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="10028">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02048605</url>
  </required_header>
  <id_info>
    <org_study_id>BSLTraining2</org_study_id>
    <nct_id>NCT02048605</nct_id>
  </id_info>
  <brief_title>Training of Psychosocial Skills for Patients With Parkinson's Disease</brief_title>
  <official_title>Basel Training Study II: Training of Psychosocial Skills for Patients With Parkinson's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peter Fuhr</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Parkinson Schweiz</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bangerter-Rhyner Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>AbbVie</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <authority>Switzerland: Ethikkommission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with Parkinson's disease (PD) will be trained using a cognitive behavioral
      group-training-program to reduce stress and augment quality of life. An unspecific  group
      with the same amount and frequency of meetings is used as a control group. For the
      evaluation of the training effects, scales to assess quality of life, analyses of
      psychopathological variations as well as neurocognitive tests will be used.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2014</start_date>
  <primary_completion_date type="Anticipated">February 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Schedule for the Evaluation of Individual Quality of Life-Direct Weighting (SeiQol-DW)</measure>
    <time_frame>Before and after training, After 6-month</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Alltagsbewältigungsskala (A-B-S) (Scale for the assessment of management of daily living)</measure>
    <time_frame>Before and after training, after 6 month</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Belastungsfragebogen für Parkinson-Patienten (burden questionnaire)</measure>
    <time_frame>Before and after training, after 6 month</time_frame>
    <safety_issue>No</safety_issue>
    <description>Questionnaire for measuring psychosocial problems, no official english translation available.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Parkinson's Disease</condition>
  <condition>Mild Cognitive Impairment</condition>
  <arm_group>
    <arm_group_label>Psycho-social cognitive-behavioral therapy based training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Based on Ellgring et al.: Psychosoziales Training bei neurologischen Erkrankungen - Schwerpunkt Parkinson</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Unspecific group training</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Health Enhancement Program
See MacCoon et al. 2012:
The validation of an active control intervention for Mindfulness Based Stress Reduction (MBSR)</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Psycho-social CBT based training</intervention_name>
    <arm_group_label>Psycho-social cognitive-behavioral therapy based training</arm_group_label>
    <other_name>According to Ellgring et al. :</other_name>
    <other_name>Psychosoziales Training bei neurologischen Erkrankungen - Schwerpunkt Parkinson</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Unspecific group training</intervention_name>
    <arm_group_label>Unspecific group training</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with idiopathic Parkinson's disease according to United Kingdom Parkinson's
             Disease Brain Bank Criteria, being either cognitively normal, suffering from Mild
             Cognitive Impairment  or having mild dementia. Patients must be able to give their
             written informed consent.

        Exclusion Criteria:

          -  Moderate or severe dementia (DMS-IV, MMS &lt;24), other neurological or psychiatric
             diseases of the brain not related to PD, secondary parkinsonism, physical impairment
             hindering the adequate execution of the training, insufficient knowledge of German or
             pregnancy are exclusion criteria. Deep Brain Stimulation (DBS) is no exclusion
             criterion.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Fuhr, Prof. Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Basel, Switzerland</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Peter Fuhr, Prof.</last_name>
    <phone>+41(0)61 265 25 25</phone>
    <email>Peter.Fuhr@usb.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital Basel</name>
      <address>
        <city>Basel</city>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Fuhr, Prof.</last_name>
      <phone>+412652525</phone>
      <email>Peter.Fuhr@usb.ch</email>
    </contact>
    <investigator>
      <last_name>Peter Fuhr, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <link>
    <url>http://parkinson-team.ch/</url>
  </link>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 20, 2014</lastchanged_date>
  <firstreceived_date>January 23, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Basel, Switzerland</investigator_affiliation>
    <investigator_full_name>Peter Fuhr</investigator_full_name>
    <investigator_title>Prof. Dr. med.</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Parkinson Disease</mesh_term>
    <mesh_term>Cognition Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
